Percutaneous injection of a low-concentration alkaline solution targeting hepatocellular carcinoma

Oncology Reports

Volumn 7, Issue 4, 2000, Pages 719-723

  Tamai, Toru ^a   Seki, Toshihito ^a   Imamura, Masato ^a   Nakagawa, Taiichi ^a   Wakabayashi, Masayuki ^a   Nishimura, Akira ^a   Yamashiki, Noriyo ^a   Shiro, Tomohiro ^a   Inoue, Kyoichi ^a   Okamura, Akiharu ^a   Harada, Kazuki ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatocellular carcinoma; NaOH; Percutaneous acetic acid injection therapy; Percutaneous ethanol injection therapy; Percutaneous low concentration alkali injection therapy; Ultrasonographic percutaneous local therapy

Indexed keywords

ALCOHOL; SODIUM HYDROXIDE;

ANIMAL; ARTICLE; INJECTION; LIVER TUMOR; MALE; NECROSIS; PATHOLOGY; PH; RAT; WISTAR RAT;

ANIMALS; ETHANOL; HYDROGEN-ION CONCENTRATION; INJECTIONS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; NECROSIS; RATS; RATS, WISTAR; SODIUM HYDROXIDE;

EID: 0034221358     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.7.4.719     Document Type: Article

References (15)

1. Seki T, Nonaka T, Kubota Y, Mizuno T and Sameshima Y: Ultrasonically guided percutaneous ethanol injection therapy for hepatocellular carcinoma. Am J Gastroenterol 84: 1400-1407, 1989.
2. Ebara M, Ohto M, Sugiura N, Kita K, Yoshikawa M, Okuda K, Kondo F and Kondo Y: Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol 5: 616-626, 1990.
3. Shiina S, Niwa Y and Omata M: Percutaneous ethanol injection therapy for liver neoplasms. Semin Intervent Radiol 10: 57-68, 1993.
4. Honda N, Guo Q, Uchida H, Ohishi H and Hiasa Y: Percutaneous hot saline injection therapy for hepatic tumors: an alternative to percutaneous ethanol injection therapy. Radiology 190: 53-57, 1994.
5. Ohnishi K, Ohyama N, Ito S and Fujiwara K: Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. Radiology 193: 747-752, 1994.
6. Ohnishi K, Nomura F, Ito S and Fujiwara K: Prognosis of small hepatocellular carcinoma (less than 3 cm) after percutaneous acetic acid injection: study of 91 cases. Hepatology 23: 994-1002, 1996.
7. Imamura M, Seki T, Kunieda K, Wakabayashi M, Nakatani S, Shiro T and Inoue K: Development of local necrosis and side-effects after hepatic injections of acetic acid solutions. Int Hepatol Commun 3: 213-216, 1995.
8. Tamai T, Seki T, Imamura M, Nakagawa T, Nishimura A, Kunieda K, Shiro T, Inoue K and Okamura A: Development of local necrosis, side-effects and histopathological study after hepatic injection of acetic acid solutions. Int Hepatol Commun 6: 153-157, 1997.
9. Seki T, Wakabayashi M, Nakagawa T, Itoh T, Shiro T, Kunieda K, Sato M, Uchiyama S and Inoue K: Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 74: 817-825, 1994.
10. Kunieda K, Seki T, Nakatani S, Wakabayashi M, Shiro T, Inoue K, Sougawa M, Kimura R and Harada K: Implantation treatment method of slow release anticancer doxorubicin containing hydroxyapatite (DOX-HAP) complex. A basic study of a new treatment for hepatic cancer. Br J Cancer 67: 668-673, 1993.
11. Imamura M, Seki T, Kunieda K, Wakabayashi M, Inoue K, Obiya Y and Harada K: Antitumor effects of doxombicin hydrochloride (DOX) and buthionine sulfoximine (BSO)-hydroxyapatite (HAP) complex on transplanted tumors in vivo. Oncol Rep 2: 509-511, 1995.
12. Imamura M, Seki T, Kunieda K, Tamai T, Nishimura A, Inoue K and Harada K: Enhancement by hyperthermia of the in vivo antitumour effect of doxorubicin hydrochloride (DOX) and buthionine sulfoximine (BSO)-hydroxyapatite (HAP) complex. Int J Oncol 10: 961-964, 1997.
13. Imamura M, Seki T, Tamai T, Nakagawa T, Nishimura A, Yamashiki N, Inoue K, Imamura M, Akagi K, Sawada S, Kasahara-Imamura M, Okamura A, Takimoto K, Watanabe H, Ohnishi T and Harada K: Preliminary investigation of resistance of plasmid DNA to neon ion beams using transformation into recipient Escherichia coli cells. Int J Mol Med 4: 57-59, 1999.
14. Ter Borg F, Timmer J, De Kam SS and Sauerwein HP: Use of sodium hydroxide solution to clear partially occluded vascular access ports. J Parenter Enterai Nutr 17: 289-291, 1993.
15. Sando K, Fujii M, Tanaka K, Chen K, Yoshida H, Iiboshi Y, Nezu R, Konishi K, Takagi Y and Okada A: Lock method using sodium hydroxide solution to clear occluded central venous access devices. Clin Nutr 16: 185-188, 1997.